Related Experiment Video
Updated: May 1, 2026
09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
4.3K
Modeling retinal dystrophies using patient-derived induced pluripotent stem cells
Karl J Wahlin1, Julien Maruotti, Donald J Zack
1Department of Ophthalmology, The Johns Hopkins University School of Medicine, Smith Building Rm 3029, 400 N Broadway, Baltimore, MD, USA, kwahlin1@jhmi.edu.
Advances in Experimental Medicine and Biology
|March 26, 2014
Summary
Induced pluripotent stem cells (iPSCs) can create 3D retinal eyecups to model retinal degenerative diseases. While promising for drug studies, challenges remain for routine use in disease modeling.
Area of Science:
- Stem cell biology
- Ophthalmology
- Regenerative medicine
Background:
- Retinal degenerative diseases cause irreversible vision loss due to photoreceptor cell death.
- Induced pluripotent stem cells (iPSCs) offer a novel in vitro approach to study these conditions.
- Patient-derived iPSCs can model specific retinal dystrophies.
Purpose of the Study:
- To explore the potential of 3D retinal eyecups derived from human iPSCs (hiPSCs) as a model for retinal degenerative diseases.
- To discuss the advancements and remaining challenges in using hiPSC-derived retinal organoids for translational drug studies.
Main Methods:
- Differentiation of hiPSCs into 3D retinal eyecup structures.
- Characterization of these structures for resemblance to the mature retina.
- Evaluation of their suitability for modeling human retinal diseases.
Main Results:
- hiPSC differentiation protocols can generate 3D retinal eyecups closely mimicking mature retinal architecture.
- These models show potential for studying disease mechanisms and testing therapeutic interventions.
- Significant challenges persist in standardizing protocols and ensuring long-term viability and functionality.
Conclusions:
- 3D hiPSC-derived retinal eyecups represent a promising, yet developing, model system for retinal degenerative diseases.
- Further research is needed to overcome current limitations before widespread clinical application in drug discovery.
- This approach holds potential for personalized medicine and understanding disease pathogenesis.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:13Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K